
Acorda Therapeutics ACOR
Quartalsbericht 2024-Q1
hinzugefügt 14.05.2024
Acorda Therapeutics Kurzfristige Verbindlichkeiten 2011-2026 | ACOR
Kurzfristige Verbindlichkeiten Jährlich Acorda Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 228 M | 38 M | 54 M | 137 M | 86.4 M | 140 M | 144 M | 148 M | 90.6 M | 114 M | 96.6 M | 98.9 M | 87.3 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 228 M | 38 M | 113 M |
Kurzfristige Verbindlichkeiten anderer Aktien in der Pharmaeinzelhändler
| Name | Kurzfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Acer Therapeutics
ACER
|
19 M | - | 2.71 % | $ 14 M | ||
|
ADMA Biologics
ADMA
|
69.5 M | $ 15.6 | -5.71 % | $ 3.72 B | ||
|
AgeX Therapeutics
AGE
|
5.91 M | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
58.7 M | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
25.2 M | - | - | $ 26.5 M | ||
|
AbCellera Biologics
ABCL
|
64.3 M | $ 3.55 | -2.34 % | $ 1.06 B | ||
|
I-Mab
IMAB
|
576 M | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
1.62 B | - | - | $ 40.3 B | ||
|
Aptorum Group Limited
APM
|
4.34 M | $ 0.82 | -0.73 % | $ 4.47 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
1.77 M | - | -1.52 % | $ 24.7 M | ||
|
Akero Therapeutics
AKRO
|
39.8 M | - | - | $ 3.67 B | ||
|
Akouos
AKUS
|
16.8 M | - | 0.23 % | $ 488 M | ||
|
Alpine Immune Sciences
ALPN
|
58 M | - | - | $ 2.17 B | ||
|
AlloVir
ALVR
|
5.24 M | - | 4.14 % | $ 49.1 M | ||
|
Apellis Pharmaceuticals
APLS
|
324 M | $ 20.14 | 1.41 % | $ 2.54 B | ||
|
Ampio Pharmaceuticals
AMPE
|
2.38 M | - | -11.43 % | $ 502 K | ||
|
ANI Pharmaceuticals
ANIP
|
194 M | $ 75.28 | -1.63 % | $ 1.45 B | ||
|
Applied Therapeutics
APLT
|
71.2 M | - | - | $ 8.42 M | ||
|
Autolus Therapeutics plc
AUTL
|
60.7 M | $ 1.47 | -9.81 % | $ 375 M | ||
|
Aravive
ARAV
|
22.1 M | - | -13.39 % | $ 1.45 M | ||
|
Adverum Biotechnologies
ADVM
|
22.9 M | - | - | $ 86.2 M | ||
|
Институт стволовых клеток человека
ISKJ
|
556 M | - | - | - | ||
|
Athersys
ATHX
|
29.9 M | - | 3.77 % | $ 22.4 M | ||
|
ARCA biopharma
ABIO
|
13 M | - | 1052.0 % | $ 415 M | ||
|
AVEO Pharmaceuticals
AVEO
|
18.7 M | - | - | $ 521 M | ||
|
Axsome Therapeutics
AXSM
|
379 M | $ 160.48 | -2.19 % | $ 7.98 B | ||
|
BridgeBio Pharma
BBIO
|
288 M | $ 65.44 | -1.65 % | $ 12.5 B | ||
|
Brainstorm Cell Therapeutics
BCLI
|
8.98 M | - | -2.5 % | $ 5.88 M | ||
|
BioDelivery Sciences International
BDSI
|
82.4 M | - | -4.8 % | $ 255 M | ||
|
Acasti Pharma
ACST
|
1.93 M | - | 4.01 % | $ 150 M | ||
|
BeiGene, Ltd.
BGNE
|
1.83 B | - | 0.49 % | $ 251 B | ||
|
Bellicum Pharmaceuticals
BLCM
|
3.77 M | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
45.5 M | - | -7.31 % | $ 87 M | ||
|
Bellerophon Therapeutics
BLPH
|
5.4 M | - | -74.18 % | $ 955 K | ||
|
BioMarin Pharmaceutical
BMRN
|
759 M | $ 60.53 | 0.17 % | $ 11.6 B | ||
|
Cabaletta Bio
CABA
|
16 M | $ 3.19 | -7.14 % | $ 3.73 M | ||
|
AIkido Pharma
AIKI
|
3.78 M | - | 1.93 % | $ 17.4 M | ||
|
Agenus
AGEN
|
256 M | $ 2.98 | -7.03 % | $ 1.07 M | ||
|
Ayala Pharmaceuticals
AYLA
|
7.54 M | - | - | $ 7.46 M | ||
|
Capricor Therapeutics
CAPR
|
31.3 M | $ 25.34 | -0.65 % | $ 679 M | ||
|
Corcept Therapeutics Incorporated
CORT
|
166 M | $ 34.35 | -3.75 % | $ 3.57 B | ||
|
Corbus Pharmaceuticals Holdings
CRBP
|
31.9 M | $ 8.02 | -4.75 % | $ 34.7 M |